Way too early to draw any conclusions on latest press release about experimental oral Covid-19 treatment based on unpublished mid-study secondary endpoints for molnupiravir.

Dr. Barry Dworkin

Medical Mythbusting Commentary for March 8, 2021

[display_podcast]

Source:
Covid-19 Pill Shows Promise in Preliminary Testing

Related posts:

  1. PM Trudeau, your flouting of pandemic health policy rules demoralizes the country. Armchair “physicians”, stop flaunting cherry-picked preprint studies as “the” evidence HCQ works when there are just as many that refute it. That is why proper investigation and meta-analysis are required.
  2. Unpublished non-peer-reviewed short-term study on possible COVID-19-induced cognitive decline used self-reported unverified data with no baseline controls or knowledge of the patients cognitive status prior to infection.
  3. Study reports that Apple watches require further evaluation to determine their ability to predict COVID-19 infection due to small study size, self-reported data, and a small number of infections within the group.
  4. Will the COVID antiviral medications be the Thor’s Hammer against SARS-CoV-2 and help mitigate the ravages of the pandemic? These are impressive drugs but there are logistical, social, geographical, and financial caveats to solve in the process.